0001415889-22-012305.txt : 20221209 0001415889-22-012305.hdr.sgml : 20221209 20221209160948 ACCESSION NUMBER: 0001415889-22-012305 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221208 FILED AS OF DATE: 20221209 DATE AS OF CHANGE: 20221209 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Straube Richard CENTRAL INDEX KEY: 0001595197 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14778 FILM NUMBER: 221454869 MAIL ADDRESS: STREET 1: 29 EMMONS DRIVE, SUITE C-10 CITY: PRINCETON STATE: NJ ZIP: 08540 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SOLIGENIX, INC. CENTRAL INDEX KEY: 0000812796 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 411505029 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE B-10 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 609-538-8200 MAIL ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE B-10 CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: DOR BIOPHARMA INC DATE OF NAME CHANGE: 20020329 FORMER COMPANY: FORMER CONFORMED NAME: ENDOREX CORP DATE OF NAME CHANGE: 19960916 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19920703 4 1 form4-12092022_091230.xml X0306 4 2022-12-08 0000812796 SOLIGENIX, INC. SNGX 0001595197 Straube Richard C/O SOLIGENIX, INC. 29 EMMONS DRIVE, SUITE B-10 PRINCETON NJ 08540 false true false false SENIOR VICE PRESIDENT AND CMO Option (Right to Buy) 0.54 2022-12-08 4 A 0 80000 0 A 2022-12-08 2032-12-07 Common Stock 80000 80000 D The stock option vested immediately as to 20,000 shares and vests as to the remainder at a rate of 5,000 of the shares on each three (3) month anniversary of December 8, 2022. /s/ Richard Straube 2022-12-09